47356 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Peter Weed ★★★★★ #5 | Outperform | $141.00→ $143.00+1.4% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Adam Tindle ★★★★★ #13 | Outperform | $115.00→ $185.00+60.9% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Ittai Kidron ★★★★★ #107 | Outperform | $170.00→ $190.00+11.8% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Rustam Kanga ★★★★☆ #482 | Market Outperform | $170.00→ $180.00+5.9% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Simeon Gutman ★★★★☆ #827 | Overweight | $180.00→ $200.00+11.1% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Rudy Kessinger ★★★★★ #58 | Buy | $165.00→ $190.00+15.2% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Eric Heath ★★★★★ #6 | Overweight | $180.00→ $190.00+5.6% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Jonathan Ruykhaver ★★★★★ #64 | Overweight | $170.00→ $200.00+17.6% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Gray Powell ★★★★★ #9 | Buy | $167.00→ $187.00+12.0% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Mike Cikos ★★★★★ #10 | Buy | $140.00→ $200.00+42.9% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Fatima Boolani ★★★★★ #49 | Neutral | $105.00→ $165.00+57.1% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Brent Thill ★★★☆☆ #1113 | Buy | $170.00→ $200.00+17.6% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Brian Essex ★★★★☆ #679 | Overweight | $165.00→ $190.00+15.2% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Keith Bachman ★★★★★ #115 | Outperform | $168.00→ $187.00+11.3% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Saket Kalia ★★★★★ #104 | Overweight | $170.00→ $180.00+5.9% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Shaul Eyal ★★★★★ #77 | Hold | $160.00→ $175.00+9.4% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Matthew Hedberg ★★★★★ #162 | Outperform | $166.00→ $195.00+17.5% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Gregg Moskowitz ★★★★★ #46 | Neutral | $145.00→ $165.00+13.8% |
|
Aug 28
00:45 UTC
|
NVDA
NVIDIA
|
◎ Target | Harlan Sur ★★★☆☆ #1487 | Overweight | $280.00→ $320.00+14.3% |
|
Aug 28
00:45 UTC
|
NVDA
NVIDIA
|
◎ Target | Srini Pajjuir not yet tracked | Outperform | $300.00→ $330.00+10.0% |
|
Aug 28
00:45 UTC
|
NVDA
NVIDIA
|
◎ Target | N. Quinn Bolton not yet tracked | Buy | $270.00→ $300.00+11.1% |
|
Aug 28
00:45 UTC
|
NVDA
NVIDIA
|
◎ Target | William Stein ★★★☆☆ #1990 | Buy | $307.00→ $346.00+12.7% |
|
Aug 28
00:45 UTC
|
NVDA
NVIDIA
|
◎ Target | Matt Bryson ★★★☆☆ #1384 | Outperform | $330.00→ $345.00+4.5% |
|
Aug 28
00:45 UTC
|
NTNX
Nutanix
|
◎ Target | Param Singh ★★★★☆ #481 | Outperform | $80.00→ $85.00+6.2% |
|
Aug 28
00:45 UTC
|
NTNX
Nutanix
|
◎ Target | Meta Marshall ★★★★☆ #498 | Equal Weight | $55.00→ $63.00+14.5% |
|
Aug 28
00:45 UTC
|
NTNX
Nutanix
|
◎ Target | Mike Cikos ★★★★★ #10 | Buy | $60.00→ $85.00+41.7% |
|
Aug 28
00:45 UTC
|
NTNX
Nutanix
|
◎ Target | Aaron Rakers ★★★★☆ #678 | Equal Weight | $55.00→ $65.00+18.2% |
|
Aug 28
00:45 UTC
|
NTNX
Nutanix
|
◎ Target | Matthew Hedberg ★★★★★ #162 | Outperform | $84.00→ $90.00+7.1% |
|
Aug 28
00:45 UTC
|
NAVN
Navan
|
◎ Target | Jed Kelly ★★★☆☆ #1651 | Outperform | $30.00→ $35.00+16.7% |
|
Aug 28
00:45 UTC
|
NA
National Bank of Canada
|
◎ Target | firm only | Sec→ r Perform | C$214.00→ C$224.00+4.7% |
|
Aug 28
00:45 UTC
|
NA
National Bank of Canada
|
◎ Target | firm only | Hold | C$227.00→ C$226.00-0.4% |
|
Aug 28
00:45 UTC
|
NA
National Bank of Canada
|
◎ Target | firm only | C$208.00→ C$212.00+1.9% | |
|
Aug 28
00:45 UTC
|
NA
National Bank of Canada
|
◎ Target | firm only | Hold | C$238.00→ C$230.00-3.4% |
|
Aug 28
00:45 UTC
|
NA
National Bank of Canada
|
◎ Target | firm only | Market Perform | C$226.50→ C$223.00-1.5% |
|
Aug 28
00:45 UTC
|
NA
National Bank of Canada
|
◎ Target | firm only | Sec→ r Outperform | C$241.00→ C$243.00+0.8% |
|
Aug 28
00:45 UTC
|
META
Meta Platforms
|
◎ Target | Barton Crockett ★★★★☆ #727 | Buy | $883.00→ $886.00+0.3% |
|
Aug 28
00:45 UTC
|
META
Meta Platforms
|
◎ Target | Youssef Squali ★★★☆☆ #984 | Buy | $770.00→ $763.00-0.9% |
|
Aug 28
00:45 UTC
|
MDXG
MiMedx Group
|
◎ Target | Chase Knickerbocker ★★★☆☆ #2194 | Buy | $6.00→ $8.00+33.3% |
|
Aug 28
00:45 UTC
|
MDT
Medtronic
|
◎ Target | Mike Matson not yet tracked | Buy | $101.00→ $114.00+12.9% |
|
Aug 28
00:45 UTC
|
LINE
Lineage
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1279 | Neutral | $46.00→ $44.00-4.3% |
|
Aug 28
00:45 UTC
|
LI
Li Auto
|
◎ Target | Alexander Potter ★☆☆☆☆ #3096 | Neutral | $15.00→ $13.00-13.3% |
|
Aug 28
00:45 UTC
|
LBRT
Liberty Energy
|
◎ Target | Derek Podhaizer ★★☆☆☆ #2740 | Overweight | $34.00→ $30.00-11.8% |
|
Aug 28
00:45 UTC
|
KYMR
Kymera Therapeutics
|
◎ Target | Derek Archila ★★☆☆☆ #2397 | Overweight | $116.00→ $151.00+30.2% |
|
Aug 28
00:45 UTC
|
KSS
Kohl's
|
◎ Target | Dana Telsey ★★★☆☆ #1342 | Market Perform | $17.00→ $18.00+5.9% |
|
Aug 28
00:45 UTC
|
KSS
Kohl's
|
◎ Target | Mark Altschwager ★★★☆☆ #2218 | Neutral | $19.00→ $20.00+5.3% |
|
Aug 28
00:45 UTC
|
KMPR
Kemper
|
◎ Target | Andrew Kligerman ★★★★☆ #850 | Buy | $81.00→ $42.00-48.1% |
|
Aug 28
00:45 UTC
|
KKR
KKR & Co. Inc.
|
◎ Target | Chris Kotowski ★★★★☆ #838 | Outperform | $139.00→ $166.00+19.4% |
|
Aug 28
00:45 UTC
|
IRM
Iron Mountain
|
◎ Target | Tobey Sommer ★★★★★ #193 | Buy | $140.00→ $155.00+10.7% |
|
Aug 28
00:45 UTC
|
IFS
Intercorp Financial Services
|
◎ Target | Yuri Fernandes ★★☆☆☆ #2626 | Neutral | $56.00→ $62.00+10.7% |
|
Aug 28
00:45 UTC
|
HPQ
HP
|
◎ Target | David Vogt ★★★★☆ #781 | Neutral | $26.00→ $28.00+7.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.